Healthcare- and wellness-focused investment firm Alkemi Growth Capital is planning to launch its third fund, with a corpus of $125-150 million, in 2027. With fresh funds, the venture capital firm is looking to expand its bets on healthcare innovation, preventive medicine and medical deep-tech startups.
In a conversation with Business Standard, Alka Goel, the firm’s founding partner, said, “We are planning to launch our third fund, targeting $125 million to $150 million, between March and June 2027.” The proposed fund will follow its first two funds of $40 million and $75 million.
Goel said Alkemi has already begun informal conversations with existing limited partners (LPs), although formal fundraising discussions have yet to begin. Alkemi has previously raised capital from the International Finance Corporation (IFC), the Teachers’ Retirement System of the State of Illinois (TRS), and the Small Industries Development Bank of India (Sidbi).
Alkemi has so far invested in 14 companies through its ongoing $75 million fund and expects to back another four over the next six months. The firm typically invests in four to six companies annually, with initial cheque sizes ranging between ₹20 crore and ₹30 crore.
Some of Alkemi’s portfolio companies include Redcliffe Labs in diagnostics, Medvital in medical devices, Datar Cancer Genetics in IVD deep-tech, Medulance in emergency medical response, Alphadroid in autonomous mobility robots, Leumas in physical AI for pharma manufacturing, and Jagruti in the mental health and rehabilitation segment, among others.
With its third fund, Alkemi is also looking to increase its exposure to deep-tech startups operating in healthcare. “We have already invested in two or three companies in deep-tech. This has happened in the last one-and-a-half years. We will definitely see more,” Goel said. With its third fund, the average ticket size is also likely to increase to ₹25-40 crore.
Beyond deep-tech, preventive healthcare is a major investment theme for the firm. Goel said rising disposable incomes and greater consumer awareness are driving spending on preventive wellness, diagnostics, wearables, nutrition and fitness. “Healthcare is forever. There is no limit to innovation in healthcare,” she said, adding that the opportunity extends beyond hospitals to pharmaceuticals, medical devices, diagnostics and preventive health.













